المؤلفون: Conteduca, Vincenza, Jayaram, Anuradha, Romero-Laorden, Nuria, Wetterskog, Daniel, Salvi, Samanta, Gurioli, Giorgia, Scarpi, Emanuela, Castro, Elena, Marin-Aguilera, Mercedes, Lolli, Cristian, Schepisi, Giuseppe, Maugeri, Antonio, Wingate, Anna, Farolfi, Alberto, Casadio, Valentina, Medina, Ana, Puente, Javier, Vidal, Mª José Méndez, Morales-Barrera, Rafael, Villa-Guzmán, Jose C., Hernando, Susana, Rodriguez-Vida, Alejo, González-del-Alba, Aránzazu, Mellado, Begoña, Gonzalez-Billalabeitia, Enrique, Olmos, David, Attard, Gerhardt, De Giorgi, Ugo, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Castration-resistant prostate cancer, Androgen receptor, Plasma DNA, Docetaxel, Androgen receptor-directed therapies, Biomarker

وصف الملف: application/pdf

العلاقة: Instituto de Salud Carlos III PI16-01565; Instituto de Salud Carlos III PI15-01499; Instituto de Salud Carlos III CM14-00200; Instituto de Salud Carlos III PI12-01226; Instituto de Salud Carlos III PI15-676; Ministerio de Economía y Competitividad JCI-2014-19129; Ministerio de Economía y Competitividad RYC-2015-18625; Ministerio de Educación, Cultura y Deporte CAS17-00182; European Urology; Vol. 75 (march 2019), p. 368-373; https://ddd.uab.cat/record/226351Test; urn:10.1016/j.eururo.2018.09.049; urn:oai:ddd.uab.cat:226351; urn:pmid:30773204; urn:pmcid:PMC6377278; urn:pmc-uid:6377278; urn:articleid:18737560v75p368; urn:scopus_id:85055497223; urn:oai:pubmedcentral.nih.gov:6377278

الإتاحة: https://ddd.uab.cat/record/226351Test

المؤلفون: Conteduca, Vincenza, Jayaram, Anuradha, Romero-Laorden, Nuria, Wetterskog, Daniel, Salvi, Samanta, Gurioli, Giorgia, Scarpi, Emanuela, Castro, Elena, Marin-Aguilera, Mercedes, Lolli, Cristian, Schepisi, Giuseppe, Maugeri, Antonio, Wingate, Anna, Farolfi, Alberto, Casadio, Valentina, Medina, Ana, Puente, Javier, Vidal, Mª José Méndez, Morales-Barrera, Rafael, Villa-Guzmán, Jose C, Hernando, Susana, Rodriguez-Vida, Alejo, González-Del-Alba, Aránzazu, Mellado, Begoña, Gonzalez-Billalabeitia, Enrique, Olmos, David, Attard, Gerhardt, De Giorgi, Ugo

مصطلحات موضوعية: Androgen receptor, Androgen receptor–directed therapies, Biomarker, Castration-resistant prostate cancer, Docetaxel, Plasma DNA, Androgen Antagonists, Androstenes, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Benzamides, Humans, Kallikreins, Male, Neoplasm Metastasis, Nitriles, Phenylthiohydantoin, Progression-Free Survival, Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Spain, Time Factors

العلاقة: http://hdl.handle.net/10668/13576Test; PMC6377278; https://doi.org/10.1016/j.eururo.2018.09.049Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377278/pdfTest

الإتاحة: https://doi.org/10.1016/j.eururo.2018.09.049Test
http://hdl.handle.net/10668/13576Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377278/pdfTest

المؤلفون: Vincenza Conteduca, Jayaram, A., Romero-Laorden, N., Wetterskog, D., Salvi, S., Gurioli, G., Scarpi, E., Castro, E., Marin-Aguilera, M., Lolli, C., Schepisi, G., Maugeri, A., Wingate, A., Farolfi, A., Casadio, V., Medina, A., Puente, J., Vidal, Mjm, Morales-Barrera, R., Villa-Guzmán, Jc, Hernando, S., Rodriguez-Vida, A., González-Del-Alba, A., Mellado, B., Gonzalez-Billalabeitia, E., Olmos, D., Attard, G., Giorgi, U.

المصدر: European Urology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Università degli studi di Foggia-IRIS

مصطلحات موضوعية: Male, Time Factors, antagonistas de andrógenos, humanos, calicreínas, androstenos, Antineoplastic Agents, Docetaxel, Article, Androgen receptor-directed therapies, factores de tiempo, antígeno prostático específico, Androgen receptor–directed therapies, Nitriles, Phenylthiohydantoin, Antineoplastic Combined Chemotherapy Protocols, Humans, antineoplásicos, Neoplasm Metastasis, metástasis neoplásica, Castration-resistant prostate cancer, protocolos de quimioterapia antineoplásica combinada, Prostatic Neoplasms, Androgen Antagonists, Biomarker, Prostate-Specific Antigen, Progression-Free Survival, feniltiohidantoína, Prostatic Neoplasms, Castration-Resistant, Androgen receptor, Plasma DNA, Receptors, Androgen, Spain, Benzamides, neoplasias de la próstata, Androstenes, Kallikreins

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5a3b2d792bd066c01c1b2f901c9f01abTest
http://europepmc.org/articles/PMC6377278Test